Cargando…

A prospective observational study of quality of diabetes care in a shared care setting: trends and age differences (ZODIAC-19)

OBJECTIVE: The Zwolle Outpatient Diabetes project Integrating Available Care (ZODIAC) study was initiated in 1998 to investigate the effects of shared care for patients with type 2 diabetes mellitus (T2DM) in the Netherlands, and to reduce the number of diabetes-related complications. Benchmarking t...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Hateren, Kornelis J J, Drion, Iefke, Kleefstra, Nanne, Groenier, Klaas H, Houweling, Sebastiaan T, van der Meer, Klaas, Bilo, Henk J G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2012
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432849/ https://www.ncbi.nlm.nih.gov/pubmed/22936821 http://dx.doi.org/10.1136/bmjopen-2012-001387

Ejemplares similares

Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50)
por: Hendriks, Steven H, et al.
Publicado: (2017)

Sex Differences in the Quality of Diabetes Care in the Netherlands (ZODIAC-45)
por: Hendriks, Steven H., et al.
Publicado: (2015)

Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56)
por: Hendriks, Steven H, et al.
Publicado: (2018)

Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)
por: Hendriks, Steven H., et al.
Publicado: (2018)

Association between 9p21 genetic variants and mortality risk in a prospective cohort of patients with type 2 diabetes (ZODIAC-15)
por: Landman, Gijs WD, et al.
Publicado: (2012)

Metformin Associated With Lower Cancer Mortality in Type 2 Diabetes: ZODIAC-16
por: Landman, Gijs W.D., et al.
Publicado: (2010)

The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2009)

Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC‐39)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol
por: Schrijnders, Dennis, et al.
Publicado: (2017)

Health-Related Quality of Life and Mortality in a General and Elderly Population of Patients With Type 2 Diabetes (ZODIAC-18)
por: Landman, Gijs W.D., et al.
Publicado: (2010)

Plasma COOH-Terminal Proendothelin-1: A marker of fatal cardiovascular events, all-cause mortality, and new-onset albuminuria in type 2 diabetes? (ZODIAC-29)
por: Drion, Iefke, et al.
Publicado: (2012)

Comparison of Methods for Renal Risk Prediction in Patients with Type 2 Diabetes (ZODIAC-36)
por: Riphagen, Ineke J., et al.
Publicado: (2015)

Demographical, Clinical, and Psychological Characteristics of Users and Nonusers of an Online Platform for T2DM Patients (e-VitaDM-3/ZODIAC-44)
por: Roelofsen, Yvonne, et al.
Publicado: (2016)

Lifestyle and emotional well-being in men and women with type 2 diabetes (e-VitaDM-4; ZODIAC-48)
por: Hendriks, Steven H., et al.
Publicado: (2017)

Within-Sulfonylurea-Class Evaluation of Time to Intensification with Insulin (ZODIAC-43)
por: Schrijnders, Dennis, et al.
Publicado: (2016)

Copeptin, a Surrogate Marker for Arginine Vasopressin, Is Associated With Cardiovascular and All-Cause Mortality in Patients With Type 2 Diabetes (ZODIAC-31)
por: Riphagen, Ineke J., et al.
Publicado: (2013)

Serum Peroxiredoxin 4: A Marker of Oxidative Stress Associated with Mortality in Type 2 Diabetes (ZODIAC-28)
por: Gerrits, Esther G., et al.
Publicado: (2014)

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2015)

Design of the e-Vita diabetes mellitus study: effects and use of an interactive online care platform in patients with type 2 diabetes (e-VitaDM-1/ZODIAC-40)
por: Roelofsen, Yvonne, et al.
Publicado: (2014)

Clinical evaluation of analytical variations in serum creatinine measurements: why laboratories should abandon Jaffe techniques
por: Drion, Iefke, et al.
Publicado: (2012)

Distribution of care expenditures for men and women with type 2 diabetes treated in primary care in the Netherlands: a case–control study (ZODIAC-59)
por: Mevissen, M R J, et al.
Publicado: (2022)

The relationship between N-terminal prosomatostatin, all-cause and cardiovascular mortality in patients with type 2 diabetes mellitus (ZODIAC-35)
por: van Dijk, Peter R, et al.
Publicado: (2015)

Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2010)

Safety and Efficacy of Gliclazide as Treatment for Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Trials
por: Landman, Gijs W. D., et al.
Publicado: (2014)

Improved Glycemic Control With Intraperitoneal Versus Subcutaneous Insulin in Type 1 Diabetes: A randomized controlled trial
por: Logtenberg, Susan J., et al.
Publicado: (2009)

Self-monitoring of blood glucose in noninsulin-treated type 2 diabetes: an overview
por: Kleefstra, Nanne, et al.
Publicado: (2009)

Patient Activation in Type 2 Diabetes: Does It Differ between Men and Women?
por: Hendriks, Steven H., et al.
Publicado: (2016)

Self-Monitoring of Blood Glucose: The Use of the First or the Second Drop of Blood
por: Hortensius, Johanna, et al.
Publicado: (2011)

Effects of three frequencies of self-monitored blood glucose on HbA1c and quality of life in patients with type 2 diabetes with once daily insulin and stable control: a randomized trial
por: Hortensius, Johanna, et al.
Publicado: (2018)

Validation of the howRu and howRwe questionnaires at the individual patient level
por: Hendriks, Steven H., et al.
Publicado: (2015)

Incidence of renal replacement therapy for diabetic nephropathy in the Netherlands: Dutch diabetes estimates (DUDE)-3
por: van Dijk, Peter R, et al.
Publicado: (2015)

Comment on: Rogers et al. Blood Pressure Trajectories Prior to Death in Patients With Diabetes. Diabetes Care 2011;34:1534–1539
por: van Hateren, K.J.J., et al.
Publicado: (2011)

Type 2 diabetes seems not to be a risk factor for the carpal tunnel syndrome: a case control study
por: Hendriks, Steven H, et al.
Publicado: (2014)

Laser therapy for onychomycosis in patients with diabetes at risk for foot complications: study protocol for a randomized, double-blind, controlled trial (LASER-1)
por: Nijenhuis-Rosien, Leonie, et al.
Publicado: (2015)

Continuous intraperitoneal insulin infusion in type 1 diabetes: a 6-year post-trial follow-up
por: van Dijk, Peter R, et al.
Publicado: (2014)

Sex differences in obesity related cancer incidence in relation to type 2 diabetes diagnosis (ZODIAC-49)
por: Schrijnders, Dennis, et al.
Publicado: (2018)

Route of Insulin Does Not Influence 25-Hydroxyvitamin D Concentrations in Type 1 Diabetes: A Brief Report
por: van Dijk, Peter R, et al.
Publicado: (2019)

Different routes of insulin administration do not influence serum free thiols in type 1 diabetes mellitus
por: van Dijk, Peter R., et al.
Publicado: (2019)

Comment on: Bosi et al. Intensive Structured Self-Monitoring of Blood Glucose and Glycemic Control in Noninsulin-Treated Type 2 Diabetes: The PRISMA Randomized Trial. Diabetes Care 2013;36:2887–2894
por: Kleefstra, Nanne, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_fbb8lv0funbi7qcr39oibfak34